OBJECTIVE: To determine the effectiveness of manualized panic-focused psychodynamic psychotherapy (PFPP) in routine care in Germany. METHOD: German psychoanalysts were trained according to the PFPP manual. Fifty-four consecutive outpatients with panic disorder (with or without agoraphobia) were randomly assigned in a 2:1 ratio to PFPP or cognitive-behavioural therapy (CBT) plus exposure therapy. Subjects (female 57.4%; mean age 36.2 years) had high rates of psychiatric (68.5%) and somatic (64.8%) comorbidity, and previous psychiatric treatments (57.4%). Assessments were performed pre- and posttreatment and at 6-month follow-up. The primary outcome measure was the Panic Disorder Severity Scale. RESULTS: Both treatments were highly effective. In patients randomized to PFPP, remission was achieved in 44.4% at termination and by 50% at follow-up (CBT 61.1% and 55.6%, respectively). No significant differences were found. Emotional awareness, a posited moderator of good outcome in psychotherapies, was significantly higher in the CBT group at baseline. It was found to be a strong moderator of treatment effectiveness in both treatments. After adjusting for initial Levels of Emotional Awareness Scale (LEAS) scores, effect sizes (ESs) for the primary outcome were Cohen d = 1.28, from pre- to posttreatment, and d = 1.03, from pretreatment to follow-up, for PFPP, and d = 1.81 and 1.28 for CBT, respectively. CONCLUSIONS:PFPP was implemented effectively into clinical practice by psychoanalysts in the community in a sample with severe mental illness with large ESs. Assessment of LEAS may facilitate the identification of patients suitable for short-term psychotherapy. ( CLINICAL TRIAL REGISTRATION NUMBER: German Clinical Trials Register, DRKS00000245; Universal Trial Number, U1111-1112-4245).
RCT Entities:
OBJECTIVE: To determine the effectiveness of manualized panic-focused psychodynamic psychotherapy (PFPP) in routine care in Germany. METHOD: German psychoanalysts were trained according to the PFPP manual. Fifty-four consecutive outpatients with panic disorder (with or without agoraphobia) were randomly assigned in a 2:1 ratio to PFPP or cognitive-behavioural therapy (CBT) plus exposure therapy. Subjects (female 57.4%; mean age 36.2 years) had high rates of psychiatric (68.5%) and somatic (64.8%) comorbidity, and previous psychiatric treatments (57.4%). Assessments were performed pre- and posttreatment and at 6-month follow-up. The primary outcome measure was the Panic Disorder Severity Scale. RESULTS: Both treatments were highly effective. In patients randomized to PFPP, remission was achieved in 44.4% at termination and by 50% at follow-up (CBT 61.1% and 55.6%, respectively). No significant differences were found. Emotional awareness, a posited moderator of good outcome in psychotherapies, was significantly higher in the CBT group at baseline. It was found to be a strong moderator of treatment effectiveness in both treatments. After adjusting for initial Levels of Emotional Awareness Scale (LEAS) scores, effect sizes (ESs) for the primary outcome were Cohen d = 1.28, from pre- to posttreatment, and d = 1.03, from pretreatment to follow-up, for PFPP, and d = 1.81 and 1.28 for CBT, respectively. CONCLUSIONS:PFPP was implemented effectively into clinical practice by psychoanalysts in the community in a sample with severe mental illness with large ESs. Assessment of LEAS may facilitate the identification of patients suitable for short-term psychotherapy. ( CLINICAL TRIAL REGISTRATION NUMBER: German Clinical Trials Register, DRKS00000245; Universal Trial Number, U1111-1112-4245).
Authors: M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp Journal: Am J Psychiatry Date: 1997-11 Impact factor: 18.112
Authors: Barbara Milrod; Andrew C Leon; Fredric Busch; Marie Rudden; Michael Schwalberg; John Clarkin; Andrew Aronson; Meriamne Singer; Wendy Turchin; E Toby Klass; Elizabeth Graf; Jed J Teres; M Katherine Shear Journal: Am J Psychiatry Date: 2007-02 Impact factor: 18.112
Authors: Barbara L Milrod; Andrew C Leon; Jacques P Barber; John C Markowitz; Elizabeth Graf Journal: J Clin Psychiatry Date: 2007-06 Impact factor: 4.384
Authors: Toshi A Furukawa; M Katherine Shear; David H Barlow; Jack M Gorman; Scott W Woods; Roy Money; Eva Etschel; Rolf R Engel; Stefan Leucht Journal: Depress Anxiety Date: 2009 Impact factor: 6.505
Authors: Dianne L Chambless; Barbara Milrod; Eliora Porter; Robert Gallop; Kevin S McCarthy; Elizabeth Graf; Marie Rudden; Brian A Sharpless; Jacques P Barber Journal: J Consult Clin Psychol Date: 2017-06-26
Authors: John R Keefe; Zeeshan M Huque; Robert J DeRubeis; Jacques P Barber; Barbara L Milrod; Dianne L Chambless Journal: Psychotherapy (Chic) Date: 2019-03-14
Authors: Jörg Wiltink; Christian Ruckes; Jürgen Hoyer; Falk Leichsenring; Peter Joraschky; Frank Leweke; Karin Pöhlmann; Manfred E Beutel Journal: BMC Psychiatry Date: 2017-03-14 Impact factor: 3.630
Authors: Ryan Smith; Richard D Lane; Anna Alkozei; Jennifer Bao; Courtney Smith; Anna Sanova; Matthew Nettles; William D S Killgore Journal: Sci Rep Date: 2018-02-22 Impact factor: 4.379
Authors: Ryan Smith; Anna Sanova; Anna Alkozei; Richard D Lane; William D S Killgore Journal: Soc Cogn Affect Neurosci Date: 2018-09-04 Impact factor: 3.436